U.S.-listed biotech buyers continued to favor asset deals over multi-billion-dollar company takeovers this week.
Pure-EV player Rivian delivered a clear third-quarter beat and raised its 2026 delivery outlook on the back of early R2 ...
U.S. stock indices ended lower on Friday, with the S&P 500 and Nasdaq also closing the month lower after investors moved out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results